Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Carcinoma of Urinary Bladder, Superficial”

405 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 405 results

Not applicableStudy completedNCT06235853
What this trial is testing

Biomarkers of Recurrence and Progression in Non-muscle Invasive Bladder Cancer

Who this might be right for
Non-muscle Invasive Bladder CancerCystoscopyRecurrence+3 more
Wroclaw Medical University 240
Not applicableUnknownNCT03138837
What this trial is testing

Role of 3 Tesla Diffusion Weighted Magnetic Resonance Imaging (DW-MRI) for Diagnosis Bladder Cancer Grade and Stage

Who this might be right for
Bladder CancerDiagnoses DiseaseMagnetic Resonance Imaging+1 more
Mansoura University 385
Large-scale testing (Phase 3)Study completedNCT00445601
What this trial is testing

S0337, Gemcitabine After Surgery in Treating Patients With Newly Diagnosed or Recurrent Bladder Cancer

Who this might be right for
Bladder Cancer
SWOG Cancer Research Network 406
Testing effectiveness (Phase 2)Looking for participantsNCT07322263
What this trial is testing

Intravesical GEM/DOCE for HR BCG-Unresponsive NMIBC

Who this might be right for
Bladder CancerNon-Muscle Invasive Bladder Cancer (NMIBC)Urothelial Carcinoma+8 more
Michael A. O'Donnell 174
Early research (Phase 1)Study completedNCT00001381
What this trial is testing

A Phase I Trial Using Suramin to Treat Superficial Transitional Cell Carcinoma of the Bladder

Who this might be right for
Bladder NeoplasmsCarcinoma, Transitional Cell
National Cancer Institute (NCI) 18
Large-scale testing (Phase 3)Not Yet RecruitingNCT07268339
What this trial is testing

A Phase III Randomised Control Clinical Trial of Radiotherapy With Radiosensitisation Versus Intravesical Bacillus Calmette-Guerin Therapy for High-risk Non-muscle Invasive Bladder Cancer.

Who this might be right for
High-Risk Non-Muscle Invasive Bladder Cancer
The Christie NHS Foundation Trust 328
Not applicableStudy completedNCT06818799
What this trial is testing

Thulium Laser En-bloc Resection of Primary Non-muscle Invasive Bladder Cancer

Who this might be right for
Bladder Transitional Cell Carcinoma
Helwan University 50
Testing effectiveness (Phase 2)Looking for participantsNCT05024734
What this trial is testing

Guiding Instillation in Non Muscle-invasive Bladder Cancer Based on Drug Screens in Patient Derived Organoids

Who this might be right for
Bladder CancerNon-muscle Invasive
Roland Seiler-Blarer 34
Not applicableNot Yet RecruitingNCT06678633
What this trial is testing

T-Control® Safety for Cytostatics Management

Who this might be right for
Non-muscle-invasive Bladder Cancer
Rethink Medical SL 16
Early research (Phase 1)Looking for participantsNCT06632964
What this trial is testing

A Clinical Trial Aimed at Assessing the Efficacy and Safety of VT-101 for the Treatment of Non-muscle Invasive Bladder Cancer

Who this might be right for
Non-muscle Invasive Bladder Cancer
The Affiliated Hospital of Xuzhou Medical University 16
Large-scale testing (Phase 3)Active Not RecruitingNCT03711032
What this trial is testing

Efficacy and Safety of Pembrolizumab (MK-3475) in Combination With Bacillus Calmette-Guerin (BCG) in High-Risk Non-Muscle Invasive Bladder Cancer (HR NMIBC) (MK-3475-676/KEYNOTE-676)

Who this might be right for
High-risk Non-muscle Invasive Bladder Cancer
Merck Sharp & Dohme LLC 1,397
Testing effectiveness (Phase 2)Study completedNCT00318643
What this trial is testing

Safety Study of Recombinant Human Hyaluronidase (Chemophase) in Combination With Mitomycin in Participants With Superficial Bladder Cancer

Who this might be right for
Bladder Cancer
Halozyme Therapeutics 27
Testing effectiveness (Phase 2)WithdrawnNCT05120622
What this trial is testing

Trial of Local Cystoscopic Injection of Tremelimumab Plus Systemic Durvalumab for High Risk Non-Muscle Invasive Bladder Cancer

Who this might be right for
Bladder CancerHigh-Risk CancerTremelimumab+2 more
University of British Columbia
Testing effectiveness (Phase 2)Looking for participantsNCT06663137
What this trial is testing

Open Label Study to Evaluate the Safety and Efficacy of NDV01 KIT in High Grade NMIBC

Who this might be right for
Non Muscle Invasive Bladder Cancer
Relmada Therapeutics, Inc. 70
Large-scale testing (Phase 3)Active Not RecruitingNCT02106572
What this trial is testing

Therapeutic Instillation of Mistletoe

Who this might be right for
Superficial Bladder Cancer
Abnoba Gmbh 548
Large-scale testing (Phase 3)UnknownNCT01082510
What this trial is testing

Study of the Efficacy of Maintenance Therapy Using Uracil-tegafur (UFT) or Bacille Calmette-Guerin (BCG) for the Prevention of Recurrences of Superficial Bladder Cancer (EMBARK Study)

Who this might be right for
Bladder Cancer
Urological Oncology Council of Northern Tokyo 288
Not applicableUnknownNCT05508568
What this trial is testing

A Performance Evaluation Study of Arquer's MCM5 Elisa Test (ADXBLADDER) to Aid in the Monitoring of Recurrence in Non-Muscle Invasive Bladder Cancer

Who this might be right for
Bladder Cancer
Arquer Diagnostics Ltd 650
Not applicableStudy completedNCT02381912
What this trial is testing

Sexual Function in Patients Suspected of Non-muscle Invasive Bladder Cancer

Who this might be right for
Urinary Bladder NeoplasmsSexual Dysfunction, PhysiologicalSexual Dysfunctions, Psychological+2 more
Herlev Hospital 210
Testing effectiveness (Phase 2)UnknownNCT04671407
What this trial is testing

The Aim of This Study is to Compare the Efficacy of Perioperative Hypertonic Saline 3% Versus Normal Saline (0.9%) in Decreasing Recurrence Risk in Non-muscle Invasive Bladder Cancer

Who this might be right for
TCC
Kaplan Medical Center 150
Not applicableLooking for participantsNCT07187063
What this trial is testing

Using Urine Tumor DNA to De-Intensify Surveillance in Non-Muscle Invasive Bladder Cancer

Who this might be right for
Non-muscle Invasive Bladder Cancer (NMIBC)
Lahey Clinic 56
Load More Results